NMPA Approval

Recombinant Coagulation Factor VIII for Injection

Approval Number

国药准字S20230044

Company正大天晴药业集团南京顺欣制药有限公司

Registration Date

August 29, 2023

Drug Information

Generic Name

注射用重组人凝血因子Ⅷ

Dosage Form

注射剂

Strength

250IU/瓶

Drug Type

生物制品

Registration Date

August 29, 2023

Company Information

Applicant Company

Company Name正大天晴药业集团南京顺欣制药有限公司

Company Address

南京市江宁区福英路1099号（江宁高新园）

Manufacturing Company

Company Name正大天晴药业集团南京顺欣制药有限公司

Company Address

南京市江宁区福英路1099号（江宁高新园）

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.